Europe

European biotech is a hot topic among investors. They have supported as many start-ups as in the US but have seen far from equivalent returns. So what's going on? Science|Business talks to biotechnology consultant John Hodgson.

A new high-speed electronic network is set to transform collaboration between 45 million researchers and students in Europe and China when it goes live later this year.

The European Union's plan to transform Europe's drug discovery industry borrows some of its style from the US - but not everything.

The European biotechnology sector is back on track, according to Ernst & Young's 20th annual survey of biotechnology.